Bigul

BAL PHARMA LTD. - 524824 - Closure of Trading Window

Pursuant to the Code of conduct of the Company and as per the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform the exchange that the trading window for dealing with the securities of the Company on the designated employees and their relatives will be closed from 1st January 2023 and up to 48 hours of the declaration of the unaudited financial results of the Company for the quarter ended 31/12/2022. The date of the Board meeting for declaration of the unaudited financial results, will be intimated to the exchange in due course.
28-12-2022
Bigul

BAL PHARMA LTD. - 524824 - EGM Voting Results & Scrutinizers Report.

We are submitting to the exchanges the results of remote e-voting for Extra Ordinary General Meeting of the Company held on 14.11.2022, along with a copy of the Scrutinizers report.
16-12-2022
Bigul

BAL PHARMA LTD. - 524824 - Proceedings Of Extra Ordinary General Meeting

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting to the exchange the business transacted at the Extra Ordinary General Meeting of the Company conducted through audio visual means, on 14.12.2022. Mr.Shailesh Siroya was elected as Chairman and he chaired the proceedings of the meeting with requisite quorum. Special Business: 1. To seek the consent of the members for filing an application under Section 230(1) of the Companies Act, 2013 with National Company Law Tribunal, Bengaluru Bench in connection with proposed merger of Wholly Owned Subsidiary Company i.e Golden Drugs Private Limited (Transferor Company) with Bal Pharma Limited (Transferee Company).
14-12-2022
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

We are submitting to the exchanges the advertisement published in Financial Express (English Version) and in Sanjayvani (Kannada Version) on 1st December 2022, regarding the public notice issued for transfer of shares of the Company to the IEPF account.
02-12-2022
Bigul

BAL PHARMA LTD. - 524824 - Disclosure Of Related Party Transactions

We are submitting to the exchanges statement of the related party transactions of the Com[pany for the half year ended 30.09.2022.
28-11-2022
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

The Company has received the letter of resignation from Mr.G.Rengarajan , CFO of the Company citing health issues and personal commitments. Mr.G.Rengarajan ceases to be the CFO of the Company from the closure of business hours on 24.11.2022.
24-11-2022
Bigul

BAL PHARMA LTD. - 524824 - Notice For The Extra Ordinary General Meeting On 14.12.2022

Extra Ordinary General Meeting of the Company is scheduled to be held on 14th December 2022 at 11.30 a.m, through audio visual means. Notice along with the details of the business to be transacted at the meeting is being dispatched to our shareholders through electronic form. A Copy of the unabridged Notice for the EGM is enclosed for submission to the exchanges. Copy of the EGM notice is also available on our website i.e www.balpharma.com.
18-11-2022
Bigul

BAL PHARMA LTD. - 524824 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding loss of share certificate/Issue of duplicate share certificate.
16-11-2022
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are submitting the press release on unaudited financial results of the Company for the quarter ended 30.09.2022, announced by us on 14.11.2022.
16-11-2022
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

We are submitting the news paper publications of unaudited financial results of the Company for the quarter ended 30.09.2022.
16-11-2022
Next Page
Close

Let's Open Free Demat Account